AgeWell.de - study protocol of a pragmatic multi-center cluster-randomized controlled prevention trial against cognitive decline in older primary care patients

In the absence of treatment options, the WHO emphasizes the identification of effective prevention strategies as a key element to counteract the dementia epidemic. Regarding the complex nature of dementia, trials simultaneously targeting multiple risk factors should be particularly effective for pre...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Zülke, Andrea (VerfasserIn) , Luck, Tobias (VerfasserIn) , Pabst, Alexander (VerfasserIn) , Hoffmann, Wolfgang (VerfasserIn) , Thyrian, Jochen René (VerfasserIn) , Gensichen, Jochen (VerfasserIn) , Kaduszkiewicz, Hanna (VerfasserIn) , König, Hans-Helmut (VerfasserIn) , Haefeli, Walter E. (VerfasserIn) , Czock, David (VerfasserIn) , Wiese, Birgitt (VerfasserIn) , Frese, Thomas (VerfasserIn) , Röhr, Susanne (VerfasserIn) , Riedel-Heller, Steffi Gerlinde (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 01 August 2019
In: BMC geriatrics
Year: 2019, Jahrgang: 19
ISSN:1471-2318
DOI:10.1186/s12877-019-1212-1
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s12877-019-1212-1
Volltext
Verfasserangaben:Andrea Zülke, Tobias Luck, Alexander Pabst, Wolfgang Hoffmann, Jochen René Thyrian, Jochen Gensichen, Hanna Kaduszkiewicz, Hans-Helmut König, Walter E. Haefeli, David Czock, Birgitt Wiese, Thomas Frese, Susanne Röhr and Steffi G. Riedel-Heller
Beschreibung
Zusammenfassung:In the absence of treatment options, the WHO emphasizes the identification of effective prevention strategies as a key element to counteract the dementia epidemic. Regarding the complex nature of dementia, trials simultaneously targeting multiple risk factors should be particularly effective for prevention. So far, however, only few such multi-component trials have been launched, but yielding promising results. In Germany, comparable initiatives are lacking, and translation of these complex interventions into routine care was not yet done. Therefore, AgeWell.de will be conducted as the first multi-component prevention trial in Germany which is closely linked to the primary care setting.
Beschreibung:Gesehen am 22.06.2020
Beschreibung:Online Resource
ISSN:1471-2318
DOI:10.1186/s12877-019-1212-1